関連する実験動画
Updated: Jun 16, 2026

10:05
Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior
Published on: September 16, 2015
ベンゾジアゼピンの依存性特性のニューラルベースは,ベンゾジアゼピンの依存性特性のニューラルベースです
Kelly R Tan1, Matthew Brown, Gwenaël Labouèbe
1Department of Basic Neurosciences, Medical Faculty, University of Geneva, CH-1211 Geneva, Switzerland.
Nature
|February 12, 2010
まとめ
ベンゾジアゼピンは,GABA (A) 受容体を調節することにより,ドーパミンニューロン活動を強化し,中毒を引き起こす. アルファ1を含有する受容体をターゲットにすることで,中毒のない薬が作れる.
科学分野:
- 神経科学は神経科学である.
- 薬理学 薬理学とは
- 依存症の研究 依存症の研究
背景:
- ベンゾジアゼピンは一般的に処方されていますが,中毒のリスクがあります.
- ベンゾジアゼピン依存症の根底にある正確な神経機構は不明である.
- 薬物中毒薬は,報酬経路におけるドーパミンシグナル伝達とシナプス可塑性を変化させます.
研究 の 目的:
- ベンゾジアゼピン依存症の神経基礎を解明するために.
- ベンゾジアゼピン誘発ドーパミンニューロン活性化におけるGABA (A) 受容体の役割を調査する.
- 依存症を誘発しないベンゾジアゼピン類の開発のための潜在的な標的を特定する.
主な方法:
- ベントラル・テグメンタル領域における電気生理学的記録.
- GABA (A) 受容体の薬理学的な操作.
- シナプス可塑性および薬物強化行動の評価.
主要な成果:
- ベンゾジアゼピンは,内部ニューロン上のGABA (A) 受容体の陽性調節を通じてドーパミンニューロン発火を増加させます.
- この効果は,α1-含有GABA (A) 受容体に依存しています.
- ベンゾジアゼピンは,このメカニズムを通じてシナプス性可塑性および薬物強化を誘導する.
結論:
- ベンゾジアゼピンは中毒薬として作用し,ドーパミンのニューロンを,腹部体領域のα1-GABA(A) 受容体を通して消去します.
- アルファ1-含有GABA (A) 受容体の細胞型特異的発現は,ベンゾジアゼピン依存症において極めて重要です.
- アルファ1サブユニットを備えたベンゾジアゼピンを開発することで,中毒性のない代替品が得られます.
関連する概念動画
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...

